Numerous non-antibiotic feed additives (alternatives to antibiotics, ATAs) have been marketed, but few have been evaluated under uniform testing conditions modelling commercial flocks. We compared 24 ATA treatments and the ionophorous coccidiostat narasin against a diet without any feed additives. Feed conversion ratio and body weight gain were registered from day 0 to 28 in Ross 308 chickens housed on litter floor. The chickens were challenged with Eimeria spp., and cecal Clostridium perfringens (CP) counts were investigated. Active components from all ATA classes had a positive impact on intestinal health or production performance. Whereas narasin had a strong CP-reducing effect in combination with performance-promoting impact, only two ATA treatments achieved significantly beneficial effects on CP counts as well as feed conversion during the time span following Eimeria challenge. Active components present in these two treatments include a Bacillus subtilis probiotic strain, short- and medium-chain fatty acids and Saccharomyces cerevisiae components. Different ATA classes had beneficial impact during distinct rearing phases and on specific performance targets, suggesting that optimizing combinations and use of active components can make ATAs even more useful tools in broiler rearing without the use of in-feed antimicrobials. Further studies of promising ATAs and ATA combinations are required.
Highly pathogenic avian influenza (HPAI) poses a substantial threat to several raptors. Between 2021 and 2023, HPAI viruses (HPAIVs) of the Goose/Guangdong lineage H5 clade 2.3.4.4b became widespread in wild birds in Norway, and H5N1 and H5N5 viruses were detected in 31 white-tailed eagles (Haliaeetus albicilla, WTEs). Post-mortem examinations of four WTEs revealed no macroscopic pathological findings. Microscopic examinations showed the presence of myocardial and splenic necroses and a few lesions in the brain.In situhybridization revealed the presence of the virus in several organs, suggesting a multisystemic infection. The detection of HPAIV H5N5 in a WTE in February 2022 marked the first recorded occurrence of this subtype in Norway. Since then, the virus has persisted, sporadically being detected in WTEs and other wild bird species. Phylogenetic analyses reveal that at least two distinct incursions of HPAIV H5N1 Eurasian (EA) genotype C affected WTEs, likely introduced by migratory birds from Eurasia and seabirds entering from Western and Central Europe. Some WTE isolates from 2021 to 2022 clustered with those from Canada and Ireland, aligning with the transatlantic spread of H5N1. Others were related to the 2021 mass mortality of great skuas in the UK or outbreaks in seabird populations, including gannets, gulls and terns, during 2022 in the North Sea region. This suggests that the WTEs were likely preying on the affected birds. Our study highlights that WTEs can act as sentinels for some HPAIV strains, but the absence of several known circulating genotypes in WTEs suggests varying pathogenic effects on this species.
1 January 2026 in Transboundary and Emerging Diseases
In 2023, highly pathogenic avian influenza (HPAI) heavily affected gulls in Europe. In July, a mass mortality event was reported in the black‐legged kittiwake ( Rissa tridactyla ) breeding colony at Ekkerøy in Northern Norway. The cause was confirmed to be infection with the HPAI H5N1 clade 2.3.4.4b virus, genotype EA‐2022‐BB. We describe the outbreak in kittiwakes, including pathological and virological investigations, and discuss the management and zoonotic potential. With more than 15,000 dead birds reported, we estimate that the outbreak caused a reduction in the kittiwake population at Ekkerøy of at least 50%. Diseased birds exhibited neurological signs. Necropsies of 10 birds revealed a peracute fatal systemic disease, with severe lesions in the brain and pancreas co‐localizing with viral RNA and antigen. Vascular expression of α2,3‐linked sialic acids (SAs) and viral RNA/antigen may reflect hematogenous viral spread. Further studies should investigate the long‐term impact of HPAI on kittiwake populations.
In 2023, highly pathogenic avian influenza (HPAI) heavily affected gulls in Europe. In July, a mass mortality event was reported in the Black-legged Kittiwake ( Rissa tridactyla ) breeding colony at Ekkerøy in Northern Norway. The cause was confirmed to be infection with the HPAI H5N1 clade 2.3.4.4b virus, genotype EA-2022-BB. We describe the outbreak in Kittiwakes, including pathological and virological investigations, and discuss the management and zoonotic potential. With more than 15,000 dead birds reported, we estimate that the outbreak caused a reduction in the Kittiwake population at Ekkerøy of at least 50%. Diseased birds exhibited neurological signs. Necropsy of ten birds revealed a peracute fatal systemic disease, with severe lesions in the brain and pancreas co-localizing with the presence of viral RNA and antigen. Vascular expression of α2,3-linked sialic acids and viral RNA/antigen may reflect hematogenous virus spread. Further studies should investigate the long-term impact of HPAI on Kittiwake populations.
Between 2022 and 2025, highly pathogenic avian influenza viruses (HPAIVs) of clade 2.3.4.4b, including four distinct H5 Eurasian (EA) genotypes, were detected in wild birds and mammals in the Svalbard Archipelago and on the island of Jan Mayen. We describe their epidemiology and genomic characteristics to improve understanding of HPAIV occurrence and transmission in the High Arctic. The initial cases in 2022 occurred during summer and involved a glaucous gull ( Larus hyperboreus ) and great skuas ( Stercorarius skua ) on Svalbard and Jan Mayen, representing the first detections of HPAIVs in the High Arctic. Three HPAIV genotypes were identified: EA-2020-C (H5N1), EA-2021-AB (H5N1) and EA-2021-I (H5N5). In 2023, HPAIVs were detected in a broader range of bird species and retrospectively in an Atlantic walrus ( Odobenus rosmarus rosmarus ) as reported by another research group. Genotypes identified in 2023 were EA-2020-C (H5N1), EA-2021-I (H5N5) and EA-2022-BB (H5N1). No cases were reported in 2024. In 2025, EA-2021-I (H5N5) was detected in Arctic foxes ( Vulpes lagopus ) on Svalbard, without preceding detections in wild birds. The foxes exhibited neurological symptoms and necropsy of one individual revealed the presence of feathers in its stomach. All sequenced viruses from the Arctic foxes uniquely carried the combination of PB2-E627K and PB1-H115Q, previously associated with mammalian adaptation. The detection of multiple genotypes indicates repeated and independent introductions of HPAIVs into these regions. The co-circulation of genetically distinct virus strains in areas of high bird density further suggests that Arctic breeding grounds may facilitate local viral amplification, reassortment and subsequent dissemination along migratory flyways, including transcontinental spread.
Between 2022 and 2025, highly pathogenic avian influenza viruses (HPAIVs) of clade 2.3.4.4b, including four distinct H5 Eurasian (EA) genotypes, were detected in wild birds and mammals in the Svalbard Archipelago and on the island of Jan Mayen. We describe their epidemiology and genomic characteristics to improve understanding of HPAIV occurrence and transmission in the High Arctic. The initial cases in 2022 occurred during summer and involved a glaucous gull ( Larus hyperboreus ) and great skuas ( Stercorarius skua ) on Svalbard and Jan Mayen, representing the first detections of HPAIVs in the High Arctic. Three HPAIV genotypes were identified: EA-2020-C (H5N1), EA-2021-AB (H5N1), and EA-2021-I (H5N5). In 2023, HPAIVs were detected in a broader range of bird species, and retrospectively in an Atlantic walrus reported by another research group ( Odobenus rosmarus rosmarus ). Genotypes identified in 2023 were EA-2020-C (H5N1), EA-2021-I (H5N5), and EA-2022-BB (H5N1). No cases were reported in 2024. In 2025, EA-2021-I (H5N5) was detected in Arctic foxes ( Vulpes lagopus ) on Svalbard, without preceding detections in wild birds. The foxes exhibited neurological symptoms, and necropsy of one individual revealed the presence of feathers in its stomach. All sequenced viruses from the Arctic foxes uniquely carried the combination of PB2-E627K and PB1-H115Q, which is associated with mammalian adaptation. The detection of multiple genotypes indicates repeated and independent introductions of HPAIVs into these regions. The co-circulation of genetically distinct virus strains in areas of high bird density further suggests that Arctic breeding grounds may facilitate local viral amplification, reassortment, and subsequent dissemination along migratory flyways, including transcontinental spread. Data summary: The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files. Influenza A whole genome sequences generated through this study are available under the GISAID accession numbers found in Table 1. All genome sequences and associated metadata supporting the findings of this study can be accessed through the persistent digital object identifier https://doi.org/10.55876/gis8.260211rq . Table 1. Detections of highly pathogenic avian influenza virus (HPAIV) in wild birds and mammals sampled in the Svalbard Archipelago and on Jan Mayen from January 1 st , 2022, to August 31 st , 2025.: